Integra Announces Completion of Refinancing Transactions
Integra LifeSciences closed a private offering of $450.0 million of 9.500% senior secured notes due 2033 and amended its credit facility to an overall size of approximately $1.65 billion. The amended Credit Facility comprises a $600 million five-year revolver, a $600 million five-year term loan A, and a $450 million seven-year term loan B. Proceeds were used together with Credit Facility borrowings to refinance the existing credit facility and pay related fees.
Key figures
- Deal Value Usd
- 450000000
- Coupon
- 9.500%
- Term loan a
- $600 million (five year maturity)
- Term loan b
- $450 million (seven year maturity)
- Notes maturity
- 2033
- Revolving facility
- $600 million (five year maturity)
- Credit facility size
- $1.65 billion
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.